EP0258692A2 - Surgical prothesis - Google Patents

Surgical prothesis Download PDF

Info

Publication number
EP0258692A2
EP0258692A2 EP87111585A EP87111585A EP0258692A2 EP 0258692 A2 EP0258692 A2 EP 0258692A2 EP 87111585 A EP87111585 A EP 87111585A EP 87111585 A EP87111585 A EP 87111585A EP 0258692 A2 EP0258692 A2 EP 0258692A2
Authority
EP
European Patent Office
Prior art keywords
lactide
laminate
polymer
poly
alumina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP87111585A
Other languages
German (de)
French (fr)
Other versions
EP0258692A3 (en
EP0258692B1 (en
Inventor
Donald James Casey
David Wei Wang
Peter Kendrick Jarrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew Inc
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of EP0258692A2 publication Critical patent/EP0258692A2/en
Publication of EP0258692A3 publication Critical patent/EP0258692A3/en
Application granted granted Critical
Publication of EP0258692B1 publication Critical patent/EP0258692B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/127Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing fillers of phosphorus-containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Definitions

  • This invention relates to surgical structural elements consisting of bioabsorbable or semi-bioabsorbable composites, as well as to products and applications using these materials.
  • Such surgical structural devices may include plates, screws, nails, pegs, rods, pins and any other device which would require a bioabsorbable material with relatively high rigidity and strength.
  • internal bone fixation is an established and clinically used technique.
  • the two major types of internal fixation devices are bone plates and intramedullary rods.
  • the particular form intended for this invention is as an internal bone fixation plate.
  • Bone plates are applicable to a large variety of bones including load bearing as well as non-load bearing bones. Presently, more long bone fixations are done with intramedullary rods. Both of these devices are traditionally made of metal, e.g. stainless steel 316. There are two major disadvantages, however, associated with the presently used metal plates:
  • the stiffness of a bone plate can be made essentially equal to the modulus of cortical bone. If the low stiffness bone plate is also bioabsorbable, it does not have to be surgically removed. Thus the need for a second surgical procedure is eliminated.
  • Bioabsorbable materials with an initial modulus and strength at or near those of cortical bone are useful as internal bone fracture fixation devices for load bearing as well as non-load bearing bones.
  • the completely bioabsorbable or semi-absorbable composites of this invention are superior in mechanical properties and in biological behavior to the stainless steel devices presently used.
  • the mechanical properties of these composites can be tailored to the specific end-use application.
  • the devices of this invention will gradually lose their mechanical properties and will ultimately fully or partially disappear.
  • a bioabsorbable device with an adjustable initial modulus which can be set at, above or below the modulus of bone, and which loses properties at a controllable, predictable rate after implantation has been invented.
  • the device may consist of a poly(l-lactide) matrix reinforced with a-alumina fibers (DuPont Fiber FP TM ) or aramid fibers (DuPont Kevlar TM ), or it may consist of a high molecular weight poly (dl-lactide) matrix reinforced with ultra high modulus polyethylene fibers (Allied A-900 TM , Allied Corp., N.J., U.S.A. These three composite systems are examples of semi--absorbable surgical devices.
  • This invention uses a combination of materials which may consist of a bioabsorbable polymer and a reinforcement fiber (which may or may not be bioabsorbable), or a bioabsorbable polymer and a bioabsorbable filler.
  • the component materials are combined in such a way as to have bending, axial and torsional stiffness and strength suitable for the biomechanical demands placed upon it.
  • the material will, subsequent to implantation, gradually lose both stiffness and strength according to the time frame for which useful properties are required.
  • the material will ultimately be completely or partially absorbed by the body, any residue being both inert in the body and bereft of significant mechanical properties. No surgical procedure to remove the device would be required.
  • a bone fixation device has been invented.
  • the device comprises an absorbable polymer and the polymer is obtained from the polymerization of 1-lactide, and a reinforcement material.
  • the polymer is obtained from the copolymerization of 1-lactide and dl-lactide. In another embodiment the polymer is obtained from the copolymerization of 1-lactide and glycolide. In a further embodiment, the polymer is obtained from the copolymerization of 1-lactide and 1,3-dioxan-2-one.
  • the reinforcement material is a filler.
  • the filler is in particulate form.
  • the particulate filler is hydroxyapatite.
  • the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
  • the reinforcement material is manufactured from a plurality of fibers.
  • the fiber material is selected from the group consisting of alumina, poly ( E -phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene.
  • the fiber is poly(p-phenylene terephthalamide).
  • the fiber is polyethylene terephthalate.
  • the fiber is alumina.
  • the fiber is alpha alumina.
  • the alternative device comprises an absorbable polymer and a reinforcement material manufactured from a plurality of ultra high modulus polyethylene fibers.
  • the absorbable polymer is obtained from the polymerization of dl-lactide.
  • the device comprises an absorbable polymer, said polymer obtained from the copolymerization of 1-lactide, dl-lactide, and a monomer selected from the group consisting of glycolide, 1, 3-dioxan-2-one, and p-dioxanone and a reinforcement material.
  • the monomer is glycolide.
  • the monomer is 1,3-dioxan--2-one.
  • the reinforcement material is a filler.
  • the filler is in particulate form.
  • the particulate fiber is hydroxyapatite.
  • the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
  • the reinforcement material is manufactured from a plurality of fibers selected from the group consisting of alumina, poly(p-phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene.
  • the fiber is alumina.
  • the fiber is alpha alumina.
  • a laminated bone fixation device has also been invented.
  • the device comprises an impregnating agent consisting of an absorbable polymer matrix.
  • the polymer is obtained from the polymerization of 1-lactide.
  • the matrix has an inherent viscosity of about 1.5 to 3.5 dl/g (0.5 g/dl in CHC1 3 ).
  • the device also comprises a nonabsorbable reinforcement material.
  • the reinforcement material consists essentially of at least one alumina fiber.
  • the device has a flexural strength of about 10,000 to 25,000 psi; a flexural modulus of about I X 10 6 to 5x10 6 psi; a loss of about 30% of initial flexural strength during 3 months in vivo and 60% during 6 months in vivo; and a loss of about 25% of initial flexural modulus during 3 months in vivo and 45% during 6 months in vivo.
  • the reinforcement material is a plurality of alpha alumina fibers. In a specific embodiment, the reinforcement material comprises about 10 to 60 volume percent of said fibers. In a more specific embodiment, the device comprises about 15 to 40 percent of said fibers. In another embodiment, the device has a flexural strength of about 15,000 to 25,000 psi. In a further embodiment, the device has a flexural modulus of up to about 3x106 psi.
  • Figures 4 to 6 show the bone fixation device.
  • the device can be manufactured without undue experimentation by methods known in the prior art, e.g. by compression molding.
  • the device can be attached to a bone by any means presently known or obvious to a person having ordinary skill in the art, for example by fastening with screws, staples and the like, or by bonding, for example, by gluing the device to the bone.
  • FIGs 4 to 6 show holes 2 which are used to each accommodate a screw 5 (shown in Figure 7). To accommodate the screw head, a plurality of holes 2 are countersunk 3 in the device 1.
  • FIG 7 the preferred relationship of the device 1 to a mammalian bone 4 fracture is shown. Under many circumstances, the configuration shown in Figure 7 will allow the best possible chance for uniform healing of the fracture in the bone 4.
  • Poly(1-lactide)-Alumina Fiber Laminate The laminate was formed from poly(l-lactide) of inherent viscosity 2.68 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" thick films were used for the -two outside layers. The laminate was consolidated by heating to 200 0 C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
  • This material is of particular interest due to it's superior in vivo performance in subcutaneous rabbit implant experiments.
  • the degradation of this material in vivo is shown in Figures 1-3.
  • Figures 1 and 2 show the physical property degradation profile and
  • Figure 3 shows the molecular weight degradation profile, as contrasted with materials used in prior art bone fixation devices.
  • the initial properties of this composite system can be varied over a wide range by varying fiber loading.
  • the degradation profile can be altered by varying the initial molecular weight of the matrix polymer.
  • Poly(1-lactide)-Kevlar Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 1.00 dl/g (0.5 g/dl in CHCl 3 , before consolidation) and a satin weave Kevlar 49 fabric. The polymer was dissolved in methylene chloride at a concentration of 5% (w/v). Kevlar fabric was immersed in the solution to form a prepreg of 22% poly(l-lactide) by weight. Poly(l-lactide) was melt pressed into films approximately 0.004" thick. Seven polymer films and six plies of prepreg were laid-up in alternating layers. The laminate was consolidated by heating at 200°C in a vacuum bag and compressing to a thickness of 1/16". The resulting laminate was 49% Kevlar by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 1.64 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
  • Poly(1-lactidey-Alumina Laminate A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 2.65 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a-thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 4.14 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. P oly(l-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195 0 C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC1 3 , before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and one film of 0.045" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Two plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 13% alumina fabric by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC1 3 , before consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and three films of 0.015" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Four plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 24% alumina fabric by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHCl 3 , before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" a.nd four films of 0.008" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Five plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 30% alumina fabric by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Alumina Laminate A laminate was formed by impregnating 1/2" chopped alumina fiber with poly(l-lactide). The polymer had an inherent viscosity of 2.64 dl/g (0.5 g/dl in CHC1 3 , before consolidation). The impregnation was accomplished by dissolving the polymer in chloroform (10 g/dl) followed by stirring in the chopped fiber. The mixture was then dried under vacuum to constant weight. The impregnated fiber was consolidated using vacuum and compression at 200°C, forming a laminate containing 30% alumina by volume. The laminate had the following mechanical properties:
  • Poly(dl-lactide)-Polyethylene Laminate A laminate was constructed using Ultra High Modulus Polyethylene (UHMPE) and poly(dl-lactide). The UHMPE fiber was laid-up in unidirectional plies with 0°, 90° orientation. Between each ply, a 0.003" thick film (melt pressed) of poly(dl-lactide) was laid. A film of polymer was placed on the top and the bottom of the lay-up as well. The laminate was consolidated by heating to 120°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 41% UHMPE by volume. The laminate had the following mechanical properties:
  • Poly(1-lactide)-Polyethylene Terephthalate Laminate Poly(l-lactide) with an initial inherent viscosity of 3.63 dl/g (0.5 g/dl in CHC1 3 ) was dissolved in CHC1 3/ ethyl acetate (V/V 9/1), at a concentration of 1 0% (w/v). Polyethylene terephthalate fabric was impregnated by dipping in the solution to a coating level of ⁇ 50% by weight. Six plies of this prepreg were then consolidated in a heated hydraulic press at 180 * C for 3 minutes with about 1500 psi pressure. The resulting laminate had a flexural modulus of 0.43 X 10 6 psi.
  • Poly-(1-lactide)-Hydroxyapatite Composite Poly-(1-lactide) was prepared by charging 100 g of 1-lactide, 15.5 ul (0.01 mole %) lauryl alcohol and 15.6 mg (0.01 mole %) stannous chloride dihydrate into a stirred reactor at 200°C. When the power drain on the stirring motor reached a maximum, 45 g of hydroxyapatite (Ca 10 (OH) 2 (PO 4 ) 6 , Mallinckrodt) was added. The composite was discharged after it appeared homogeneous (about 5 min.). The composite contained about 14% hydroxyapatite by volume.
  • the flexural properties of a compression molded plaque were:

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Prostheses (AREA)

Abstract

A bone fixation device is disclosed. The device comprises an absorbable homopolymer of I-lactide or dl-lactide, or a copolymer of I-lactide, and a reinforcement material. The reinforcement material can be a particulate filler of hydro- , xyapatite or a plurality of alumina fibers.

Description

    BACKGROUND-OF THE INVENTION
  • This invention relates to surgical structural elements consisting of bioabsorbable or semi-bioabsorbable composites, as well as to products and applications using these materials. Such surgical structural devices may include plates, screws, nails, pegs, rods, pins and any other device which would require a bioabsorbable material with relatively high rigidity and strength.
  • The use of internal bone fixation is an established and clinically used technique. The two major types of internal fixation devices are bone plates and intramedullary rods. The particular form intended for this invention is as an internal bone fixation plate.
  • Bone plates are applicable to a large variety of bones including load bearing as well as non-load bearing bones. Presently, more long bone fixations are done with intramedullary rods. Both of these devices are traditionally made of metal, e.g. stainless steel 316. There are two major disadvantages, however, associated with the presently used metal plates:
    • 1) Metal plates have a modulus approximately one order of magnitude greater than cortical bone.
  • This mismatch in stiffness is known to cause stress protection induced osteoporosis or os- teopenia. The increase in porosity and decrease in cortical wall thickness results in a weakened bone which is prone to refracture once the bone plate is removed.
    • 2) The metal plates must be removed due to their nonbiodegradable nature coupled with the eventual possibility of corrosion. A second surgical procedure is therefore required which may introduce further complications.
  • The use of lower stiffness materials such as nonabsorbable composites and tubular steel have been investigated. However, no human trials of these materials are known.
  • Lower stiffness bone fixation devices have advantages over metal plates. For example the stiffness of a bone plate can be made essentially equal to the modulus of cortical bone. If the low stiffness bone plate is also bioabsorbable, it does not have to be surgically removed. Thus the need for a second surgical procedure is eliminated.
  • Considerable research has therefore been devoted to the development of low stiffness bone plate materials. The properties which are most desirable in a bone plate are:
    • 1) The bone plate should provide a firm fixation of the broken bone to promote union during the early stages of healing.
    • 2) Once union has occurred, the load which was initially supported. by the bone plate, would be gradually transferred back to the bone. This would induce the formation of stronger more dense bone at the fracture site thus accelerating the healing process.
    • 3) After the bone heals (3 to 6 months after implantation) the bone plate would completely lose its ability to support a load. The bone would then be once again subjected to its normal stresses.
  • Bioabsorbable materials with an initial modulus and strength at or near those of cortical bone are useful as internal bone fracture fixation devices for load bearing as well as non-load bearing bones.
  • The completely bioabsorbable or semi-absorbable composites of this invention are superior in mechanical properties and in biological behavior to the stainless steel devices presently used. The mechanical properties of these composites can be tailored to the specific end-use application. The devices of this invention will gradually lose their mechanical properties and will ultimately fully or partially disappear.
  • SUMMARY OF THE INVENTION
  • A bioabsorbable device with an adjustable initial modulus which can be set at, above or below the modulus of bone, and which loses properties at a controllable, predictable rate after implantation has been invented. The device may consist of a poly(l-lactide) matrix reinforced with a-alumina fibers (DuPont Fiber FPTM) or aramid fibers (DuPont KevlarTM), or it may consist of a high molecular weight poly (dl-lactide) matrix reinforced with ultra high modulus polyethylene fibers (Allied A-900TM, Allied Corp., N.J., U.S.A. These three composite systems are examples of semi--absorbable surgical devices.
  • This invention uses a combination of materials which may consist of a bioabsorbable polymer and a reinforcement fiber (which may or may not be bioabsorbable), or a bioabsorbable polymer and a bioabsorbable filler. The component materials are combined in such a way as to have bending, axial and torsional stiffness and strength suitable for the biomechanical demands placed upon it. The material will, subsequent to implantation, gradually lose both stiffness and strength according to the time frame for which useful properties are required. The material will ultimately be completely or partially absorbed by the body, any residue being both inert in the body and bereft of significant mechanical properties. No surgical procedure to remove the device would be required.
  • A bone fixation device has been invented. The device comprises an absorbable polymer and the polymer is obtained from the polymerization of 1-lactide, and a reinforcement material.
  • In one embodiment, the polymer is obtained from the copolymerization of 1-lactide and dl-lactide. In another embodiment the polymer is obtained from the copolymerization of 1-lactide and glycolide. In a further embodiment, the polymer is obtained from the copolymerization of 1-lactide and 1,3-dioxan-2-one.
  • In yet another embodiment, and in combination with any of the above embodiments, the reinforcement material is a filler. In a specific embodiment, the filler is in particulate form. In a more specific embodiment, the particulate filler is hydroxyapatite. In another specific embodiment, the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
  • In a still further embodiment, and in combination with any of the above polymer embodiments, the reinforcement material is manufactured from a plurality of fibers. The fiber material is selected from the group consisting of alumina, poly (E-phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene. In a specific embodiment the fiber is poly(p-phenylene terephthalamide). In another specific embodiment, the fiber is polyethylene terephthalate. In a further specific embodiment, the fiber is alumina.
  • In a more specific embodiment, the fiber is alpha alumina.
  • An alternative bone fixation device has been invented. The alternative device comprises an absorbable polymer and a reinforcement material manufactured from a plurality of ultra high modulus polyethylene fibers. The absorbable polymer is obtained from the polymerization of dl-lactide.
  • Another alternative bone fixation device has been invented. The device comprises an absorbable polymer, said polymer obtained from the copolymerization of 1-lactide, dl-lactide, and a monomer selected from the group consisting of glycolide, 1, 3-dioxan-2-one, and p-dioxanone and a reinforcement material. In one embodiment, the monomer is glycolide. In another embodiment, the monomer is 1,3-dioxan--2-one.
  • In yet another embodiment, and in combination with any of the above alternative bone fixation device embodiments, the reinforcement material is a filler. In a specific embodiment, the filler is in particulate form. In a more specific embodiment, the particulate fiber is hydroxyapatite. In another specific embodiment, the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
  • In a still further embodiment, and in combination with any of the above (alternative device) polymer embodiments, the reinforcement material is manufactured from a plurality of fibers selected from the group consisting of alumina, poly(p-phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene. In a specific embodiment, the fiber is alumina. In a more specific embodiment, the fiber is alpha alumina.
  • A laminated bone fixation device has also been invented. The device comprises an impregnating agent consisting of an absorbable polymer matrix. The polymer is obtained from the polymerization of 1-lactide. The matrix has an inherent viscosity of about 1.5 to 3.5 dl/g (0.5 g/dl in CHC13). The device also comprises a nonabsorbable reinforcement material. The reinforcement material consists essentially of at least one alumina fiber. The device has a flexural strength of about 10,000 to 25,000 psi; a flexural modulus of about IX106 to 5x106 psi; a loss of about 30% of initial flexural strength during 3 months in vivo and 60% during 6 months in vivo; and a loss of about 25% of initial flexural modulus during 3 months in vivo and 45% during 6 months in vivo.
  • In one embodiment, the reinforcement material is a plurality of alpha alumina fibers. In a specific embodiment, the reinforcement material comprises about 10 to 60 volume percent of said fibers. In a more specific embodiment, the device comprises about 15 to 40 percent of said fibers. In another embodiment, the device has a flexural strength of about 15,000 to 25,000 psi. In a further embodiment, the device has a flexural modulus of up to about 3x106 psi.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • Figure 1 is a graph showing the in vivo flexural modulus degradation of the device of this invention, as contrasted with the moduli of prior art bone fixation devices;
    • Figures 2 and 3 are graphs, similar to that of Figure 1, showing in vivo flexural strength and molecular weight degradation, respectively;
    • Figure 4 is a top view of a bone fixation device manufactured from the composite materials of this invention;
    • Figure 5 is a partially broken side view of Figure 4;
    • Figure 6 is a front view of Figure 5; and
    • Figure 7 is a broken perspective view of Figures 4 to 6 showing the use of the device on a mammalian bone.
    DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The following is a description for making the composite materials used in the bone fixation device of this invention.
  • 1. Bioabsorbable Particulate Filled Systems
    • A) A monomer or monomer mixture is polymerized in bulk in a stirred reactor under nitrogen or vacuum. When the polymer melt viscosity reaches a maximum the particulate filler is added slowly to the concentration desired.
    • B) A bioabsorbable matrix polymer is heated to melting under nitrogen or vacuum in a mixing chamber. To the melt, the particulate filler (tricalcium phosphate or hydroxyapatite) is added slowly until thorough mixing is observed at the desired concentration.
    2. Fiber Reinforced Systems
    • A) Solution Impregnation and Laminations: The fiber or woven fabric is immersed in a solution of the biodegradable polymer in a low boiling point solvent (e.g. methylene chloride). The amount of polymer deposited on the fabric, chopped fiber or fiber yarn is dependent on the solution concentration, the polymer molecular weight (which effects solution viscosity) , the length of immersion time and the number of immersions. The impregnated chopped fiber, yarn or fabric (prepreg) is then thoroughly dried. The prepreg is laid-up in a mold of a predetermined thickness. Vacuum is applied to the lay-up by use of a vacuum bag. Heat and compression are then applied to consolidate the laminate.
    • B) Melt Impregnation and Lamination: Films of the biodegradable polymer are made by solvent casting or melt pressing. Alternatively, fibrous mats are made from polymer by running a solution of the polymer into a non-solvent in a thin stream to form a stringy precipitate, followed by pressing into a mat at room temperature. The films or mats are then laid between yarn or fabric layers in a mold of a predetermined thickness. Vacuum is applied to the lay-up, by vacuum-bagging the mold, and heat and compression are applied to consolidate the laminate.
  • Figures 4 to 6 show the bone fixation device. The device can be manufactured without undue experimentation by methods known in the prior art, e.g. by compression molding. The device can be attached to a bone by any means presently known or obvious to a person having ordinary skill in the art, for example by fastening with screws, staples and the like, or by bonding, for example, by gluing the device to the bone.
  • Figures 4 to 6 show holes 2 which are used to each accommodate a screw 5 (shown in Figure 7). To accommodate the screw head, a plurality of holes 2 are countersunk 3 in the device 1.
  • Referring specifically to Figures 4 and 5, four holes 2 are shown. It is to be understood that any number of holes can be used, provided the device 1 is adequately attached to a bone 4 (shown in Figure 7). However, as a minimum, at least two holes 2 and screws 5 appear to be necessary.
  • Referring to Figure 7, the preferred relationship of the device 1 to a mammalian bone 4 fracture is shown. Under many circumstances, the configuration shown in Figure 7 will allow the best possible chance for uniform healing of the fracture in the bone 4.
  • The following examples more fully describe the above embodiments.
  • Example 1
  • Poly(1-lactide)-Alumina Fiber Laminate: The laminate was formed from poly(l-lactide) of inherent viscosity 2.68 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" thick films were used for the -two outside layers. The laminate was consolidated by heating to 2000C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0001
    Figure imgb0002
  • This material is of particular interest due to it's superior in vivo performance in subcutaneous rabbit implant experiments. The degradation of this material in vivo is shown in Figures 1-3. Figures 1 and 2 show the physical property degradation profile and Figure 3 shows the molecular weight degradation profile, as contrasted with materials used in prior art bone fixation devices. The initial properties of this composite system can be varied over a wide range by varying fiber loading. In addition, the degradation profile can be altered by varying the initial molecular weight of the matrix polymer.
  • Mechanical properties declined in a roughly linear manner over a 6 month period in rabbits to a level at 39% of initial flexural strength and 53% of initial flexural modulus. Inherent viscosity data suggest that mass loss of the poly(l-lactide) matrix would begin after approximately 42 weeks. After mass loss onset, the rate of mechanical property degradation should increase and any remaining load bearing capability would quickly deteriorate.
  • Example 2
  • Poly(1-lactide)-Kevlar Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 1.00 dl/g (0.5 g/dl in CHCl3, before consolidation) and a satin weave Kevlar 49 fabric. The polymer was dissolved in methylene chloride at a concentration of 5% (w/v). Kevlar fabric was immersed in the solution to form a prepreg of 22% poly(l-lactide) by weight. Poly(l-lactide) was melt pressed into films approximately 0.004" thick. Seven polymer films and six plies of prepreg were laid-up in alternating layers. The laminate was consolidated by heating at 200°C in a vacuum bag and compressing to a thickness of 1/16". The resulting laminate was 49% Kevlar by volume. The laminate had the following mechanical properties:
    Figure imgb0003
    Figure imgb0004
  • Example 3
  • Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 1.64 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0005
    Figure imgb0006
  • Example 4
  • Poly(1-lactidey-Alumina Laminate: A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 2.65 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a-thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0007
    Figure imgb0008
  • Example 5
  • Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 4.14 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 1950C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0009
    Figure imgb0010
  • A summary of the flexural strength and flexural modulus data for Examples 3 to 5 is contained in the following Table.
    Figure imgb0011
  • Example 6
  • Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and one film of 0.045" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Two plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 13% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0012
    Figure imgb0013
  • Example 7
  • Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0014
    Figure imgb0015
  • Example 8
  • Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and three films of 0.015" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Four plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 24% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0016
    Figure imgb0017
  • Example 9
  • Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHCl3, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" a.nd four films of 0.008" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Five plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 30% alumina fabric by volume. The laminate had the following mechanical properties:
    Figure imgb0018
    Figure imgb0019
  • A summary of the flexural strength and flexural modulus data for Examples 6 to 9 is contained in the following Table.
    Figure imgb0020
  • Example 10
  • Poly(1-lactide)-Alumina Laminate: A laminate was formed by impregnating 1/2" chopped alumina fiber with poly(l-lactide). The polymer had an inherent viscosity of 2.64 dl/g (0.5 g/dl in CHC13, before consolidation). The impregnation was accomplished by dissolving the polymer in chloroform (10 g/dl) followed by stirring in the chopped fiber. The mixture was then dried under vacuum to constant weight. The impregnated fiber was consolidated using vacuum and compression at 200°C, forming a laminate containing 30% alumina by volume. The laminate had the following mechanical properties:
    Figure imgb0021
    Figure imgb0022
  • Exampl*e 11
  • In Vitro Degradation of Poly(l-lactide)-Alumina Laminates: An accelerated in vitro degradation test was used to assess the relative degradation rates of laminates made with poly(1-lactide)s of different molecular weights reinforced with alumina fabric. The in vitro procedure involved immersing the sample in a pH 6.09 phosphate buffered aqueous solution at 67°C. The samples were removed from the bath, dried and tested for mechanical properties using the ASTM D790 method. Samples from Examples 3, 4 and 5 were used in this study. The results are shown in Table I. These data indicate that the composite fabricated with the lower molecular weight polymer (Example 3) possessed higher initial mechanical properties than the composites made with higher molecular weight polymers. It also appeared to have less scatter in its degradation profile.
  • Example 12
  • In Vitro Degradation of Poly(1-lactide)-Alumina Laminates: An accelerated in vitro degradation test was used to assess the relative degradation rates of laminates made with poly(l-lactide) reinforced with different loadings of alumina fabric. The in vitro procedure was identical to that described in Example 11. Samples from Examples 6, 7, 8 and 9 were used in this study. The results are shown in Table II. These data indicate that the composites possessed higher initial mechanical properties as the fabric volume increased. This relationship allows the tailoring of a material to have the mechanical properties desirable for a specific application within a fairly broad range.
  • Example 13
  • Poly(dl-lactide)-Polyethylene Laminate: A laminate was constructed using Ultra High Modulus Polyethylene (UHMPE) and poly(dl-lactide). The UHMPE fiber was laid-up in unidirectional plies with 0°, 90° orientation. Between each ply, a 0.003" thick film (melt pressed) of poly(dl-lactide) was laid. A film of polymer was placed on the top and the bottom of the lay-up as well. The laminate was consolidated by heating to 120°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 41% UHMPE by volume. The laminate had the following mechanical properties:
  • Figure imgb0023
    Figure imgb0024
  • Example 14
  • Poly(1-lactide)-Polyethylene Terephthalate Laminate: Poly(l-lactide) with an initial inherent viscosity of 3.63 dl/g (0.5 g/dl in CHC13) was dissolved in CHC13/ethyl acetate (V/V 9/1), at a concentration of 10% (w/v). Polyethylene terephthalate fabric was impregnated by dipping in the solution to a coating level of~50% by weight. Six plies of this prepreg were then consolidated in a heated hydraulic press at 180*C for 3 minutes with about 1500 psi pressure. The resulting laminate had a flexural modulus of 0.43 X 106 psi.
  • Example 15
  • Poly(l-lactide)-Hydroxyapatite Composite: Poly-(1-lactide) was prepared by charging 100 g of 1-lactide, 15.5 ul (0.01 mole %) lauryl alcohol and 15.6 mg (0.01 mole %) stannous chloride dihydrate into a stirred reactor at 200°C. When the power drain on the stirring motor reached a maximum, 45 g of hydroxyapatite (Ca10(OH)2(PO4)6, Mallinckrodt) was added. The composite was discharged after it appeared homogeneous (about 5 min.). The composite contained about 14% hydroxyapatite by volume. The flexural properties of a compression molded plaque were:
    Figure imgb0025
    Figure imgb0026

Claims (10)

1. A bone fixation device comprising an absorbable polymer, said polymer obtained from the polymerization of 1- lactide, and a reinforcement material.
2. A device of claim 1 wherein said polymer is obtained from the copolymerization of 1-lactide and dl-lactide.
3. A device of claim 1 wherein said polymer is obtained from the copolymerization of 1-lactide and glycolide.
4. A device of claim 1 wherein said polymer is obtained from the copolymerization of 1-lactide and -1,3-dioxan-2-one.
5. A device of claim 1 or 2 or 3 or 4 wherein the reinforcement material is a filler.
6. A device of claim 5 wherein the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
7. A device of claim 1 or 2 or 3 or 4 wherein the reinforcement material is manufactured from a plurality of fibers selected from the group consisting of alumina, poly-(p-phenylene terephthalamide), polyethylene terephthalate and ultra high modulus polyethylene.
8. A device of claim 1 or 2 or 3 or 4 wherein said polymer has an inherent viscosity of about 1.5 to 3.5 dl/g (0.5 g/dl in CHC13).
9. A device of claim 8 wherein said reinforcement material consists essentially of at least one alumina fiber, said device having a flexural strength of about 10,000 to 25,000 psi; a flexural modulus of about 1x106 to 5x106 psi; a loss of about 30% of its initial flexural strength during 3 months in vivo and 60% during 6 months in vivo; and a loss of about 25% of its initial flexural modulus during 3 months in vivo and 45% during 6 months in vivo.
10. A device of claim 9 comprising about 10 to 60 volume percent of said alumina fibers.
EP87111585A 1986-08-27 1987-08-11 Surgical prothesis Expired - Lifetime EP0258692B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US900957 1986-08-27
US06/900,957 US4781183A (en) 1986-08-27 1986-08-27 Surgical prosthesis

Publications (3)

Publication Number Publication Date
EP0258692A2 true EP0258692A2 (en) 1988-03-09
EP0258692A3 EP0258692A3 (en) 1990-04-04
EP0258692B1 EP0258692B1 (en) 1994-06-15

Family

ID=25413362

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87111585A Expired - Lifetime EP0258692B1 (en) 1986-08-27 1987-08-11 Surgical prothesis

Country Status (13)

Country Link
US (1) US4781183A (en)
EP (1) EP0258692B1 (en)
JP (1) JPS6389166A (en)
KR (1) KR950008174B1 (en)
AU (1) AU599413B2 (en)
CA (1) CA1263791A (en)
DE (1) DE3750061T2 (en)
DK (1) DK169278B1 (en)
ES (1) ES2054634T3 (en)
FI (1) FI873700A (en)
IL (1) IL83538A (en)
NO (1) NO172169C (en)
ZA (1) ZA876366B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352972A2 (en) * 1988-07-29 1990-01-31 BAXTER INTERNATIONAL INC. (a Delaware corporation) Fiber-reinforced expanded fluoroplastic vascular grafts
DE3831657A1 (en) * 1988-09-17 1990-03-22 Boehringer Ingelheim Kg DEVICE FOR THE OSTEOSYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF
GR880100802A (en) * 1988-11-28 1990-12-31 Petros Koutsoukos Deposition of xydroxyapatite on modified polymers
DE4243913A1 (en) * 1991-12-25 1993-07-01 Gunze Kk Pins for holding fractured bones together whilst the fracture is healing - are made from biologically degradable polymer and do not need to be removed after the fracture has healed
DE19805673A1 (en) * 1998-02-12 1999-08-26 Quante Production of injectable bone replacement and augmentation material that hardens at site of application

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6368155A (en) * 1986-09-11 1988-03-28 グンゼ株式会社 Bone bonding pin
FI81498C (en) * 1987-01-13 1990-11-12 Biocon Oy SURGICAL MATERIAL OCH INSTRUMENT.
US4966599A (en) * 1987-04-07 1990-10-30 Pollock Richard A Anatomical precontoured plating, instruments and methods
BR8707937A (en) * 1987-11-03 1990-02-13 Synthes Ag PROSTHESIS FOR OSTEOSYNTHESIS
CH673762A5 (en) * 1987-12-02 1990-04-12 Synthes Ag
DE3841288A1 (en) * 1988-12-08 1990-06-13 Pertti Prof Dr Toermaelae OSTEOSYNTHESE IMPLANTS
US5290494A (en) * 1990-03-05 1994-03-01 Board Of Regents, The University Of Texas System Process of making a resorbable implantation device
US5080665A (en) * 1990-07-06 1992-01-14 American Cyanamid Company Deformable, absorbable surgical device
CA2060635A1 (en) * 1991-02-12 1992-08-13 Keith D'alessio Bioabsorbable medical implants
EP0523926A3 (en) * 1991-07-15 1993-12-01 Smith & Nephew Richards Inc Prosthetic implants with bioabsorbable coating
US5391768A (en) * 1993-03-25 1995-02-21 United States Surgical Corporation Purification of 1,4-dioxan-2-one by crystallization
US5721049A (en) * 1993-11-15 1998-02-24 Trustees Of The University Of Pennsylvania Composite materials using bone bioactive glass and ceramic fibers
US6121172A (en) * 1993-11-15 2000-09-19 The Trustees Of The University Of Pennsylvania Composite materials using bone bioactive glass and ceramic fibers
US5468544A (en) * 1993-11-15 1995-11-21 The Trustees Of The University Of Pennsylvania Composite materials using bone bioactive glass and ceramic fibers
US5569250A (en) * 1994-03-01 1996-10-29 Sarver; David R. Method and apparatus for securing adjacent bone portions
US20020169485A1 (en) 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US6944501B1 (en) * 2000-04-05 2005-09-13 Neurospace, Inc. Neurostimulator involving stimulation strategies and process for using it
US6696499B1 (en) * 1996-07-11 2004-02-24 Life Medical Sciences, Inc. Methods and compositions for reducing or eliminating post-surgical adhesion formation
US5711958A (en) * 1996-07-11 1998-01-27 Life Medical Sciences, Inc. Methods for reducing or eliminating post-surgical adhesion formation
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
FI105159B (en) * 1996-10-25 2000-06-30 Biocon Ltd Surgical implant, agent or part thereof
JP3426460B2 (en) * 1996-10-25 2003-07-14 グンゼ株式会社 Osteosynthesis
JP3718306B2 (en) * 1997-01-06 2005-11-24 経憲 武井 Artificial acetabulum and hip joint
ATE395001T1 (en) 1997-02-11 2008-05-15 Warsaw Orthopedic Inc PLATE FOR THE FRONT CERVICAL SPINE WITH FIXATION SYSTEM FOR ONE SCREW
AU6145998A (en) 1997-02-11 1998-08-26 Gary Karlin Michelson Skeletal plating system
US6211249B1 (en) 1997-07-11 2001-04-03 Life Medical Sciences, Inc. Polyester polyether block copolymers
US5935127A (en) * 1997-12-17 1999-08-10 Biomet, Inc. Apparatus and method for treatment of a fracture in a long bone
JPH11206871A (en) * 1998-01-27 1999-08-03 Bmg:Kk In vivo degradable and absorptive bone fixing material and its manufacture
US5938664A (en) * 1998-03-31 1999-08-17 Zimmer, Inc. Orthopaedic bone plate
US6206883B1 (en) 1999-03-05 2001-03-27 Stryker Technologies Corporation Bioabsorbable materials and medical devices made therefrom
CA2367085C (en) * 1999-03-09 2007-08-07 Synthes (U.S.A.) Bone plate with partly-threaded elongated hole
US6783529B2 (en) 1999-04-09 2004-08-31 Depuy Orthopaedics, Inc. Non-metal inserts for bone support assembly
US6296645B1 (en) 1999-04-09 2001-10-02 Depuy Orthopaedics, Inc. Intramedullary nail with non-metal spacers
DE19936133C2 (en) * 1999-07-31 2002-11-21 Aesculap Ag & Co Kg Plastic bone plate
US6473639B1 (en) 2000-03-02 2002-10-29 Neuropace, Inc. Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures
US6466822B1 (en) 2000-04-05 2002-10-15 Neuropace, Inc. Multimodal neurostimulator and process of using it
US6395033B1 (en) * 2000-04-10 2002-05-28 Tyco Healthcare Group Lp Dynamic fusion mechanostat devices
US6605090B1 (en) * 2000-10-25 2003-08-12 Sdgi Holdings, Inc. Non-metallic implant devices and intra-operative methods for assembly and fixation
US6529774B1 (en) 2000-11-09 2003-03-04 Neuropace, Inc. Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation
US7005135B2 (en) * 2001-01-30 2006-02-28 Ethicon Inc. Glass scaffolds with controlled resorption rates and methods for making same
KR100383433B1 (en) * 2001-06-29 2003-05-12 주식회사 씨엠리서치 Method for preparing bioabsorbable organic/inorganic composition for bone fixation devices and itself prepared thereby
US6747121B2 (en) 2001-09-05 2004-06-08 Synthes (Usa) Poly(L-lactide-co-glycolide) copolymers, methods for making and using same, and devices containing same
US7682392B2 (en) 2002-10-30 2010-03-23 Depuy Spine, Inc. Regenerative implants for stabilizing the spine and devices for attachment of said implants
US7951176B2 (en) 2003-05-30 2011-05-31 Synthes Usa, Llc Bone plate
ES2348987T3 (en) 2003-08-26 2010-12-21 Synthes Gmbh BONE PLATE.
US11259851B2 (en) 2003-08-26 2022-03-01 DePuy Synthes Products, Inc. Bone plate
AU2003257355B2 (en) 2003-09-08 2008-05-29 Synthes Gmbh Bone fixing device
US8016865B2 (en) * 2003-09-29 2011-09-13 Depuy Mitek, Inc. Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
US7699879B2 (en) * 2003-10-21 2010-04-20 Warsaw Orthopedic, Inc. Apparatus and method for providing dynamizable translations to orthopedic implants
US20050085814A1 (en) * 2003-10-21 2005-04-21 Sherman Michael C. Dynamizable orthopedic implants and their use in treating bone defects
WO2005041796A1 (en) * 2003-10-30 2005-05-12 Synthes Gmbh Bone plate
ATE540628T1 (en) 2003-12-01 2012-01-15 Smith & Nephew Inc HUMERAL NAIL WITH INSERT FOR FIXING A SCREW
US20050136764A1 (en) * 2003-12-18 2005-06-23 Sherman Michael C. Designed composite degradation for spinal implants
US8574268B2 (en) 2004-01-26 2013-11-05 DePuy Synthes Product, LLC Highly-versatile variable-angle bone plate system
US11291484B2 (en) 2004-01-26 2022-04-05 DePuy Synthes Products, Inc. Highly-versatile variable-angle bone plate system
US7637928B2 (en) 2004-01-26 2009-12-29 Synthes Usa, Llc Variable angle locked bone fixation system
US20060173458A1 (en) * 2004-10-07 2006-08-03 Micah Forstein Bone fracture fixation system
US8545866B2 (en) 2004-10-29 2013-10-01 Smith & Nephew, Inc. Bioabsorbable polymers
DE602005013262D1 (en) * 2004-10-29 2009-04-23 Smith & Nephew Inc BIOABSORBABLE POLYMERS WITH CALCIUM CARBONATE
US8394130B2 (en) 2005-03-17 2013-03-12 Biomet C.V. Modular fracture fixation system
US8062296B2 (en) * 2005-03-17 2011-11-22 Depuy Products, Inc. Modular fracture fixation plate system with multiple metaphyseal and diaphyseal plates
US7410488B2 (en) 2005-02-18 2008-08-12 Smith & Nephew, Inc. Hindfoot nail
US7727278B2 (en) * 2005-03-04 2010-06-01 Rti Biologics, Inc. Self fixing assembled bone-tendon-bone graft
US7763071B2 (en) * 2005-03-04 2010-07-27 Rti Biologics, Inc. Bone block assemblies and their use in assembled bone-tendon-bone grafts
US7763072B2 (en) * 2005-03-04 2010-07-27 Rti Biologics, Inc. Intermediate bone block and its use in bone block assemblies and assembled bone-tendon-bone grafts
US8470038B2 (en) 2005-03-04 2013-06-25 Rti Biologics, Inc. Adjustable and fixed assembled bone-tendon-bone graft
US20060247638A1 (en) * 2005-04-29 2006-11-02 Sdgi Holdings, Inc. Composite spinal fixation systems
US20070118128A1 (en) * 2005-11-22 2007-05-24 Depuy Spine, Inc. Implant fixation methods and apparatus
US20070118130A1 (en) * 2005-11-22 2007-05-24 Depuy Spine, Inc. Implant fixation methods and apparatus
US20070118129A1 (en) * 2005-11-22 2007-05-24 Depuy Spine, Inc. Implant fixation methods and apparatus
US20070118127A1 (en) * 2005-11-22 2007-05-24 Depuy Spine, Inc. Implant fixation methods and apparatus
US20070154514A1 (en) * 2005-12-30 2007-07-05 Demakas John J Therapeutic Structures
US7867261B2 (en) * 2006-03-17 2011-01-11 Depuy Products, Inc. Bone plate with variable torsional stiffness at fixed angle holes
US8221468B2 (en) * 2006-05-11 2012-07-17 Gaines Jr Robert W Use of bioabsorbable materials for anterior extradiscal correction of thoracolumbar pathologies
US7923020B2 (en) * 2006-09-29 2011-04-12 Depuy Products, Inc. Composite for implantation in the body of an animal and method for making the same
EP2131750B1 (en) * 2007-03-06 2016-05-04 Covidien LP Wound closure material
US20100076489A1 (en) * 2007-03-06 2010-03-25 Joshua Stopek Wound closure material
JP5034786B2 (en) * 2007-08-30 2012-09-26 東レ株式会社 Easy degradable film
JP5330392B2 (en) 2007-09-18 2013-10-30 ストライカー トラウマ ゲーエムベーハー Stable fixation system by implant angle
US20090138092A1 (en) * 2007-11-28 2009-05-28 Johnston Brent W Therapeutic Structures for Utilization in Temporomandibular Joint Replacement Systems
US8100949B2 (en) * 2008-06-03 2012-01-24 Warsaw Orthopedic, Inc. Transverse rod connectors with osteoconductive material
US9642658B2 (en) * 2008-10-15 2017-05-09 Orthoclip Llc Device and method for delivery of therapeutic agents via internal implants
US20100130959A1 (en) * 2008-10-15 2010-05-27 Palmetto Biomedical, Inc. Device and method for delivery of therapeutic agents via artificial internal implants
CN102497830A (en) 2009-09-14 2012-06-13 斯恩蒂斯有限公司 Variable angle compression plate
US9011494B2 (en) 2009-09-24 2015-04-21 Warsaw Orthopedic, Inc. Composite vertebral rod system and methods of use
US8709092B2 (en) 2011-02-16 2014-04-29 Genesis Medical Devices, LLC Periprosthetic fracture management enhancements
JP6502161B2 (en) * 2015-05-11 2019-04-17 帝人メディカルテクノロジー株式会社 Bone cement
US10687874B2 (en) 2015-08-27 2020-06-23 Globus Medical, Inc Proximal humeral stabilization system
US11076898B2 (en) 2015-08-27 2021-08-03 Globus Medical, Inc. Proximal humeral stabilization system
US11197682B2 (en) 2015-08-27 2021-12-14 Globus Medical, Inc. Proximal humeral stabilization system
US10130402B2 (en) 2015-09-25 2018-11-20 Globus Medical, Inc. Bone fixation devices having a locking feature
US9974581B2 (en) 2015-11-20 2018-05-22 Globus Medical, Inc. Expandable intramedullary systems and methods of using the same
US9795411B2 (en) 2016-03-02 2017-10-24 Globus Medical, Inc. Fixators for bone stabilization and associated systems and methods
US10531905B2 (en) 2016-04-19 2020-01-14 Globus Medical, Inc. Implantable compression screws
US10751098B2 (en) 2016-08-17 2020-08-25 Globus Medical Inc. Stabilization systems
US11432857B2 (en) 2016-08-17 2022-09-06 Globus Medical, Inc. Stabilization systems
US10420596B2 (en) 2016-08-17 2019-09-24 Globus Medical, Inc. Volar distal radius stabilization system
US11331128B2 (en) 2016-08-17 2022-05-17 Globus Medical Inc. Distal radius stabilization system
US11197701B2 (en) 2016-08-17 2021-12-14 Globus Medical, Inc. Stabilization systems
US10575884B2 (en) 2016-08-17 2020-03-03 Globus Medical, Inc. Fracture plates, systems, and methods
US10383668B2 (en) 2016-08-17 2019-08-20 Globus Medical, Inc. Volar distal radius stabilization system
US11141204B2 (en) 2016-08-17 2021-10-12 Globus Medical Inc. Wrist stabilization systems
US11213327B2 (en) 2016-08-17 2022-01-04 Globus Medical, Inc. Fracture plates, systems, and methods
US10687873B2 (en) 2016-08-17 2020-06-23 Globus Medical Inc. Stabilization systems
US10905476B2 (en) 2016-09-08 2021-02-02 DePuy Synthes Products, Inc. Variable angle bone plate
US10624686B2 (en) 2016-09-08 2020-04-21 DePuy Synthes Products, Inc. Variable angel bone plate
US10820930B2 (en) 2016-09-08 2020-11-03 DePuy Synthes Products, Inc. Variable angle bone plate
US10881438B2 (en) 2017-03-10 2021-01-05 Globus Medical, Inc. Clavicle fixation system
US10905477B2 (en) 2017-03-13 2021-02-02 Globus Medical, Inc. Bone stabilization systems
US10368928B2 (en) 2017-03-13 2019-08-06 Globus Medical, Inc. Bone stabilization systems
US10856920B2 (en) 2017-09-13 2020-12-08 Globus Medical Inc. Bone stabilization systems
US11096730B2 (en) 2017-09-13 2021-08-24 Globus Medical Inc. Bone stabilization systems
JP6842170B2 (en) * 2017-09-28 2021-03-17 国立大学法人 岡山大学 Manufacturing method of biological tissue adhesive and biological tissue adhesive
US11224468B2 (en) 2018-03-02 2022-01-18 Globus Medical, Inc. Distal tibial plating system
US11071570B2 (en) 2018-03-02 2021-07-27 Globus Medical, Inc. Distal tibial plating system
US11026727B2 (en) 2018-03-20 2021-06-08 DePuy Synthes Products, Inc. Bone plate with form-fitting variable-angle locking hole
US10772665B2 (en) 2018-03-29 2020-09-15 DePuy Synthes Products, Inc. Locking structures for affixing bone anchors to a bone plate, and related systems and methods
US11141172B2 (en) 2018-04-11 2021-10-12 Globus Medical, Inc. Method and apparatus for locking a drill guide in a polyaxial hole
US11013541B2 (en) 2018-04-30 2021-05-25 DePuy Synthes Products, Inc. Threaded locking structures for affixing bone anchors to a bone plate, and related systems and methods
US10925651B2 (en) 2018-12-21 2021-02-23 DePuy Synthes Products, Inc. Implant having locking holes with collection cavity for shavings
US11202663B2 (en) 2019-02-13 2021-12-21 Globus Medical, Inc. Proximal humeral stabilization systems and methods thereof
US11129627B2 (en) 2019-10-30 2021-09-28 Globus Medical, Inc. Method and apparatus for inserting a bone plate
US11723647B2 (en) 2019-12-17 2023-08-15 Globus Medical, Inc. Syndesmosis fixation assembly

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364644A1 (en) * 1976-09-20 1978-04-14 Inst Nat Sante Rech Med NEW MATERIAL FOR BONE PROSTHESIS AND ITS APPLICATION
EP0011528B1 (en) * 1978-10-20 1985-02-20 Centre National De La Recherche Scientifique (Cnrs) Osteosynthesis elements and their preparation
EP0146398A2 (en) * 1983-12-19 1985-06-26 Southern Research Institute Method of producing biodegradable prothesis and products therefrom
WO1986000533A1 (en) * 1984-07-10 1986-01-30 Rijksuniversiteit Te Groningen Bone implant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR11528E (en) * 1908-09-29 1910-03-05 Maurice Baudou Puncture-proof and puncture-proof pneumatic tire for the wheels of all vehicles
DE2546824C2 (en) * 1975-10-18 1986-05-07 Ernst Leitz Wetzlar Gmbh, 6330 Wetzlar Coated endoprosthesis and process for their manufacture
US4512038A (en) * 1979-04-27 1985-04-23 University Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4338926A (en) * 1980-11-21 1982-07-13 Howmedica, Inc. Bone fracture prosthesis with controlled stiffness
DK154260C (en) * 1981-02-20 1989-05-22 Mundipharma Gmbh PROCEDURE FOR THE MANUFACTURING OF A BONE IMPLANT OF FURNISHED TRICAL CUMPHOSPHATE, SPECIFICALLY FOR FILLING OF SPACES OR FOR COMPOSITION OF BONE PARTS AFTER FRACTURE.
US4550449A (en) * 1982-11-08 1985-11-05 Johnson & Johnson Products Inc. Absorbable bone fixation device
ES526645A0 (en) * 1982-12-02 1985-09-01 Wallone Region IMPROVEMENTS INTRODUCED IN THE PROCESS TO OBTAIN BIOREACTIVE MATERIALS
US4636526A (en) * 1985-02-19 1987-01-13 The Dow Chemical Company Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364644A1 (en) * 1976-09-20 1978-04-14 Inst Nat Sante Rech Med NEW MATERIAL FOR BONE PROSTHESIS AND ITS APPLICATION
EP0011528B1 (en) * 1978-10-20 1985-02-20 Centre National De La Recherche Scientifique (Cnrs) Osteosynthesis elements and their preparation
EP0146398A2 (en) * 1983-12-19 1985-06-26 Southern Research Institute Method of producing biodegradable prothesis and products therefrom
WO1986000533A1 (en) * 1984-07-10 1986-01-30 Rijksuniversiteit Te Groningen Bone implant

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352972A2 (en) * 1988-07-29 1990-01-31 BAXTER INTERNATIONAL INC. (a Delaware corporation) Fiber-reinforced expanded fluoroplastic vascular grafts
EP0352972A3 (en) * 1988-07-29 1991-01-02 BAXTER INTERNATIONAL INC. (a Delaware corporation) Fiber-reinforced expanded fluoroplastic vascular grafts
DE3831657A1 (en) * 1988-09-17 1990-03-22 Boehringer Ingelheim Kg DEVICE FOR THE OSTEOSYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF
GR880100802A (en) * 1988-11-28 1990-12-31 Petros Koutsoukos Deposition of xydroxyapatite on modified polymers
DE4243913A1 (en) * 1991-12-25 1993-07-01 Gunze Kk Pins for holding fractured bones together whilst the fracture is healing - are made from biologically degradable polymer and do not need to be removed after the fracture has healed
DE4243913C2 (en) * 1991-12-25 2000-10-05 Gunze Kk Bone treatment devices and methods of making them
DE19805673A1 (en) * 1998-02-12 1999-08-26 Quante Production of injectable bone replacement and augmentation material that hardens at site of application
DE19805673C2 (en) * 1998-02-12 2002-09-26 Wolfgang Quante Process and kit for making bone replacement and augmentation material

Also Published As

Publication number Publication date
KR950008174B1 (en) 1995-07-26
NO873598L (en) 1988-02-29
JPS6389166A (en) 1988-04-20
FI873700A0 (en) 1987-08-26
FI873700A (en) 1988-02-28
DK169278B1 (en) 1994-10-03
ES2054634T3 (en) 1994-08-16
DE3750061D1 (en) 1994-07-21
DK446187A (en) 1988-02-28
US4781183A (en) 1988-11-01
NO172169B (en) 1993-03-08
AU599413B2 (en) 1990-07-19
DK446187D0 (en) 1987-08-26
IL83538A (en) 1992-03-29
EP0258692A3 (en) 1990-04-04
AU7746487A (en) 1988-03-03
KR880002496A (en) 1988-05-09
EP0258692B1 (en) 1994-06-15
DE3750061T2 (en) 1995-01-26
NO873598D0 (en) 1987-08-26
ZA876366B (en) 1988-04-27
CA1263791A (en) 1989-12-05
NO172169C (en) 1993-06-16
IL83538A0 (en) 1988-01-31

Similar Documents

Publication Publication Date Title
EP0258692A2 (en) Surgical prothesis
Matsusue et al. In vitro and in vivo studies on bioabsorbable ultra‐high‐strength poly (l‐lactide) rods
Vainionpää et al. Strength and strength retention vitro, of absorbable, self-reinforced polyglycolide (PGA) rods for fracture fixation
EP0460439B1 (en) Deformable surgical device
Bos et al. Bio-absorbable plates and screws for internal fixation of mandibular fractures: A study in six dogs
US4655777A (en) Method of producing biodegradable prosthesis and products therefrom
US4743257A (en) Material for osteosynthesis devices
US6147135A (en) Fabrication of biocompatible polymeric composites
US7541049B1 (en) Bioactive and biodegradable composites of polymers and ceramics or glasses and method to manufacture such composites
Agrawal et al. Fabrication and characterization of PLA-PGA orthopedic implants
Zimmerman et al. The design and analysis of a laminated partially degradable composite bone plate for fracture fixation
EP1874366A2 (en) A bioabsorbable and bioactive composite material and a method for manufacturing the composite
FI83477B (en) ABSORBER MATERIAL FOER FIXERING AV VAEVNADER.
Bleach et al. Effect of filler type on the mechanical properties of self-reinforced polylactide–calcium phosphate composites
Deb et al. Effect of crosslinking agents on acrylic bone cements based on poly (methylmethacrylate)
Dauner et al. Resorbable continuous-fibre reinforced polymers for osteosynthesis
Hasirci et al. High strength bioresorbable bone plates: preparation, mechanical properties and in vitro analysis
Fambri et al. Characterization of modulus and glass transition phenomena in poly (L‐lactide)/hydroxyapatite composites
FI78238C (en) SURGICAL PURPOSE SYNTHESIS.
Kellomäki et al. Pliable polylactide plates for guided bone regeneration: manufacturing and in vitro
Eitenmuller et al. New Semi-Rigid and Absorbable Osteosynthesis Devices with a High Molecular Weight Polylactide (An Experimental Investigation
Casper et al. Biodegradable fracture fixation plates for use in maxillofacial surgery
Klein et al. Filament-wound composite soft tissue prostheses: controlling compliance and strength by water absorption and degradation
Hedjazi Assessment of processing techniques for Orthopaedic Composites
Kim et al. Partially biodegradable bone cement for bone ingrowth (I): Preparation and physical properties

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): BE CH DE ES FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): BE CH DE ES FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19901004

17Q First examination report despatched

Effective date: 19910610

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AMERICAN CYANAMID COMPANY

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE CH DE ES FR GB IT LI NL SE

REF Corresponds to:

Ref document number: 3750061

Country of ref document: DE

Date of ref document: 19940721

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2054634

Country of ref document: ES

Kind code of ref document: T3

ET Fr: translation filed
ITF It: translation for a ep patent filed

Owner name: MODIANO & ASSOCIATI S.R.L.

EAL Se: european patent in force in sweden

Ref document number: 87111585.3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PUE

Owner name: AMERICAN CYANAMID COMPANY TRANSFER- ACUFEX MICROSU

Ref country code: CH

Ref legal event code: NV

Representative=s name: BOVARD AG PATENTANWAELTE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19960802

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19960809

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19960815

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19960816

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19960821

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19960828

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 19960830

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19961003

Year of fee payment: 10

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

Owner name: ACUFEX MICROSURGICAL, INC.

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

NLS Nl: assignments of ep-patents

Owner name: ACUFEX MICROSURGICAL INC.

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970811

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970812

Ref country code: ES

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 19970812

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970831

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970831

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970831

BERE Be: lapsed

Owner name: ACUFEX MICROSURGICAL INC.

Effective date: 19970831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980301

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19970811

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980501

EUG Se: european patent has lapsed

Ref document number: 87111585.3

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 19980301

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20001204

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060831

Year of fee payment: 20